Market Tracker

03/29 5:16pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

11.70
Delayed Data
As of 3:59pm ET
 +0.10 / +0.86%
Today’s Change
4.10
Today|||52-Week Range
15.05
+151.61%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close11.60
Today’s open11.65
Day’s range11.60 - 12.24
Volume1,062,411
Average volume (3 months)1,497,822
Market cap$694.3M
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-15.94%
Earnings growth (this year)+11.25%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,496.53
Price/Book18.36

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.37+2.30%
HSKAHeska Corp0.000.00%
AMPHAmphastar Pharmaceut...+0.06+0.41%
ADROAduro Biotech Inc+0.45+4.25%
Data as of 3:59pm ET, 03/29/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$152.4K
Annual profit (last year)-$78.3M
Net profit margin-51,353.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts